Kihara James

PRINCIPAL ACCOUNTING OFFICER

Kihara James has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 29, 2026.

On the most recent filing, Kihara James is listed as PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC. Inside the rolling window, Kihara James reported no open-market purchases and 7 open-market sales totaling $603K in ACAD. The largest disclosed transaction in the window is a sale of 11,421 ACAD shares on Jun 26, 2026, worth $298K.

Companies traded

Other insiders at ACAD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$603K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ACADSale$298KJun 29SEC ↗
ACADSale$114KMay 27SEC ↗
ACADSale$29KMay 5SEC ↗
ACADSale$23KApr 7SEC ↗
ACADSale$18KMar 26SEC ↗
ACADSale$24KMar 26SEC ↗
ACADSale$97KNov 19SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Kihara James made?

Kihara James has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does Kihara James trade?

Kihara James has filed SEC Form 4 disclosures for 1 company, including ACAD.

When was Kihara James's most recent SEC Form 4 filing?

Kihara James's most recent SEC Form 4 filing on Tracefour is dated Jun 29, 2026.

What is Kihara James's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Kihara James is listed as PRINCIPAL ACCOUNTING OFFICER.

What is Kihara James's total buy and sell value in the current window?

Inside the rolling retention window, Kihara James bought $0 and sold $603K based on SEC Form 4 filings.

What was Kihara James's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 11,421 ACAD shares on 2026-06-26, worth $298K, per SEC Form 4 filings.